Publication Topic

Urban JD, Tachovsky JA, Haws LC, Staskal DF, Harris MA. 2010. Response to Buchanan et al.’s comment on Urban et al. “Assessment of Human Health Risks Posed by Consumption of Fish from the Lower Passaic River, New Jersey.” Sci Tot Environ 408(8):2004-2007.

Kelsh MA, Morimoto L, Lau E. Cancer mortality and oil production in the Amazon region of Ecuador. 2009. Int Arch Occup Environ Health 82(3): 381–395.

Thompson CM, Grafstrom RC. 2009. Commentary: Mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma. Environ Health 8:53; doi: 10.1186/1476-069X-8-53.

Lea IA, Jackson MA, Dunnick JK. 2009. Genetic pathways to colorectal cancer. Mutat Res 670(1–2):96–98; doi: 10.1016/j.mrfmmm.2009.06.011.

Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath D, Levy DD…Robison TW, et al. 2009. Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol Sci 109(2):172-179; doi: 10.1093/toxsci/kfp067.

Luo W, Nordstrom BL, Fraeman K, Nordyke RJ, Ranganathan G, Linz HE, Winterkorn A, Stokes M, et al. 2008. Adherence to guidelines for use of ESAs in patients with chemotherapy-induced anemia: Results of a retrospective study of an EMR database in the US, 2002-2006. Clin Ther 30(12):2423-35; doi: 10.1016/j.clinthera.2008.12.022. PMID: 19167601.

Nordstrom BL, Weixiu L, Fraeman KH, Whyte JL, Nordyke RJ. 2008. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter. J Manag Care Pharm 14(9):858-69; doi: 10.18553/jmcp.2008.14.9.858. PMID: 19006442.

Kelsh MA, Alexander DD, Kalmes RM, Buffler PA. 2008. Personal use of hair dyes and risk of bladder cancer: A meta-analysis of epidemiologic data. Cancer Causes Control 19(6):549–558.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.

Subramaniam RP, Chen C, Crump KS, Devoney D, Fox JF, Portier CJ, Schlosser PM, Thompson CM, White P. 2008. Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: Identification of key issues. Risk Analysis 28(4):907–923; doi: 10.1111/j.1539-6924.2008.01083.x.

Alexander DD, Kelsh MA, Mink PJ, Mandel JH, Basu R, Weingart W. 2007. A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health 81(2):127–143; doi: 10.1007/s00420-007-0201-4. PMID: 17492303.

Proctor DM, Gatto NM, Hong SJ, Allamneni KP. 2007. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol Sci 98(2):313–326; doi: 10.1093/toxsci/kfm075.

Buffler PA, Kelsh MA, Kalmes RL, Lau E, Chapman PC, Wood S, et al. 2007. A nested case-control study of brain tumors among employees at a petroleum exploration and extraction research facility. J Occup Environ Med 49(7):791–802; doi: 10.1097/JOM.0b013e318076b7bf. PMID: 17622853.

Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. 2007. Genetic pathways and mutation profiles of human cancers: Site- and exposure-specific patterns. Carcinogenesis 28(9):1851–1858; doi: 10.1093/carcin/bgm176.

Teta MJ, Lau E, Sceurman BK, Wagner ME. 2007. Therapeutic radiation for lymphoma: Risk of malignant mesothelioma. Cancer 109(7):1432–1438; doi: 10.1002/cncr.22526.

Alexander DD, Mink PJ, Mandel JH, Kelsh MA. 2006. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukemia. Occup Med 56(7):485–493; doi: 10.1093/occmed/kql083. PMID: 16905622.

Mandel JH, Kelsh MA, Mink PJ, Alexander D, Kalmes RM, Weingart M, et al. 2006. Occupational trichloroethylene exposure and non-Hodgkins lymphoma: A meta-analysis and review. Occup Environ Med 63(9):597–607; doi: 10.1136/oem.2005.022418. PMID: 16644896.

David RM, Clewell HJ, Gentry PR, Covington TR, Morgott DA, Marino DJ. 2006. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regul Toxicol Pharmacol 45(1):55–65; doi: 10.1016/j.yrtph.2005.12.003.

Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA. 2006. Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose-response modeling in mice. Regul Toxicol Pharmacol 45(1):44–54; doi: 10.1016/j.yrtph.2005.12.007.

Degregorio MW, Dingley KH, Wurz GT, Ubick E, Turteltaub KW. 2006. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations. Cancer Chemother Pharmacol 57(3):335-342; doi: 10.1007/s00280-005-0060-1. PMID: 16047147.